Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
JPMI-Journal of Postgraduate Medical Institute. 2004; 18 (4): 598-601
em Inglês | IMEMR | ID: emr-67109

RESUMO

To evaluate the clinical and biochemical outcome of patients with advanced prostate cancer treated by complete androgen blockage [CAB]. A total number of thirty patients with histologically confirmed advance prostate cancer and serum PSA level of more than 30ng/ml were subjected to bilateral subcapsular orchidectomy, supplemented with oral antiandrogens. These patients were followed for a period of two years by recording their symptoms and serum PSA level at twelve weeks intervals. Only 16[53.33%] patients complied with the protocol of the study and observed two years followup. 12[75%] patients showed complete response to CAB while 4[25%] patients showed rising PSA levels and became symptomatic after one year of treatment. CAB is still the treatment of choice for patients with advanced prostate cancer


Assuntos
Humanos , Masculino , Antagonistas de Androgênios , Flutamida , Orquiectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA